US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

succinylcholine

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6011-2 D-0026-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0025-2024
Class II · Moderate risk Terminated

fentaNYL in dextrose 5%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0024-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0023-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0022-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0021-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0020-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0019-2024
Class II · Moderate risk Terminated

midazolam in dextrose 5%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-4036-1 D-0018-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2074-1 D-0014-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-5 D-0013-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-4 D-0012-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-3 D-0011-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0010-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0009-2024
Class II · Moderate risk Terminated

rocuronium

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0008-2024
Class II · Moderate risk Terminated

PHENYLephrine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6009-1 D-0007-2024
Class II · Moderate risk Terminated

PHENYLephrine in 0.9 sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6008-1 D-0006-2024
Class II · Moderate risk Terminated

lidocaine 2%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0004-2024
Class II · Moderate risk Terminated

ePHEDrine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-0003-2024
Class II · Moderate risk Terminated

ketamine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-3022-1 D-0002-2024